IGC Pharma (IGC) Shares Outstanding (Diluted Average) (2010 - 2026)

IGC Pharma (IGC) has 12 years of Shares Outstanding (Diluted Average) data on file, last reported at $98.2 million in Q1 2026.

• Shares Outstanding (Diluted Average) for Q1 2026 came in at $98.2 million, up 23.23% year-over-year; the trailing twelve-month figure through Mar 2026 was $98.2 million (up 23.23% YoY), and the FY2026 annual result was $98.2 million, up 23.23% from the prior year.
• Shares Outstanding (Diluted Average) rose to $98.2 million in Q1 2026 per IGC's latest filing, from $86.8 million in the prior quarter.
• Over five years, Shares Outstanding (Diluted Average) peaked at $98.2 million in Q1 2026 and troughed at $53.7 million in Q3 2023.
• A 4-year average of $74.7 million and a median of $75.0 million in 2024 frame the typical range for Shares Outstanding (Diluted Average).
• The sharpest annual moves came in 2024 and 2025: Shares Outstanding (Diluted Average) soared 38.59% in 2024, then grew 14.03% in 2025.
• A 4-year view of Shares Outstanding (Diluted Average) shows it stood at $63.7 million in 2023, then increased by 18.47% to $75.5 million in 2024, then increased by 14.93% to $86.8 million in 2025, then climbed by 13.14% to $98.2 million in 2026.
• Business Quant data shows IGC's Shares Outstanding (Diluted Average) at $98.2 million in Q1 2026, $86.8 million in Q3 2025, and $83.0 million in Q2 2025.